Osteopontin, CD44, and NFkappaB expression in gastric adenocarcinoma.
OBJECTIVE
Osteopontin (OPN) binds to CD44 and nuclear factor-kappaB (NFkappaB) and OPN mediates tumorigenesis, invasion and metastasis, but the interrelationships between OPN, CD44 and NFkappaB are not fully understood, and especially in gastric carcinogenesis. We examined the expressions of OPN, CD44, and NFkappaB in untreated gastric adenocarcinomas.


METHODS
The materials from 211 cases of gastric adenocarcinoma were immunostained for OPN, CD44 and NFkappaB by using a tissue microarray. The OPN mRNA expression was measured in 10 cases by performing real-time RT-PCR.


RESULTS
The expression of OPN, CD44 and NFkappaB was noted in 61.7%, 11.4% and 26.6% of the adenocarcinoma tissues, respectively. No significant correlation was detected among the expressions of these proteins. The OPN protein expression was negatively correlated with angioinvasion (p<0.05) and patient survival (p<0.05), whereas the CD44 and NFkappaB protein expressions were not correlated with any of the clinicopathological factors we examined. The depth of invasion, lymph node status and perineural invasions were prognostic factors based on the Cox analysis. The OPN mRNA expression showed no significant difference between the adenocarcinoma and the paired normal mucosa on real-time RT-PCR.


CONCLUSIONS
OPN may have a currently undetermined role in gastric carcinogenesis, and CD44 and NFkappaB may have minor roles in gastric adenocarcinoma.
Kim
Jung Yeon
JY
Department of Pathology, Inje University Sanggye Paik Hospital, Seoul, Korea.
Bae
Byung-Noe
BN
Kim
Kyoung Soo
KS
Shin
Eunah
E
Park
Kyeongmee
K
J Biol Chem. 2005 Jan 28;280(4):2708-13
15557322
Cancer Res. 2007 Mar 1;67(5):2089-97
17332338
Appl Immunohistochem Mol Morphol. 2004 Mar;12(1):67-70
15163022
J Gastroenterol Hepatol. 2008 Mar;23(3):351-65
18318820
J Mammary Gland Biol Neoplasia. 2001 Oct;6(4):419-29
12013531
Methods. 2001 Dec;25(4):402-8
11846609
Biochim Biophys Acta. 2001 Dec 28;1552(2):61-85
11825687
J Biol Chem. 2003 Apr 18;278(16):14487-97
12473670
J Clin Oncol. 2005 May 20;23(15):3526-35
15908663
Oncogene. 2003 Feb 27;22(8):1198-205
12606946
Clin Exp Metastasis. 2004;21(6):515-23
15679049
Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):184-90
14734468
Mol Carcinog. 2005 Aug;43(4):225-36
15864800
Gut. 2007 Jun;56(6):782-9
17148500
Scand J Surg. 2006;95(4):225-31
17249269
J Biol Chem. 2004 Feb 6;279(6):4541-50
14623895
Carcinogenesis. 2005 Apr;26(4):741-51
15661802
J Biol Chem. 2009 Jan 30;284(5):2657-2671
19047049
Genes Dev. 2002 Dec 1;16(23):3074-86
12464636
J Biol Chem. 2001 Nov 30;276(48):44926-35
11564733
J Clin Endocrinol Metab. 2005 Sep;90(9):5270-8
15998773
Mol Cancer. 2007 Jan 16;6:6
17227585
J Oral Pathol Med. 2007 Jan;36(1):30-4
17181739
J Neurooncol. 2008 Feb;86(3):285-96
17928956